SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending amid a mixed sentiment, with some traders pointing to a recent report highlighting security flaws in its battlefield communication system while others dismiss it as a hit piece designed to create a buying opportunity. The community is actively debating the company's valuation and future growth prospects in the AI space, with some calling it overvalued and others believing it has significant long-term potential. Despite the debate, some are taking advantage of the dip and loading up on shares, anticipating a rebound.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending after announcing a partnership with Perplexity AI to enhance content discovery and bundle services, sparking community excitement about AI integration. Discussions also revolve around Rumble's ties to cryptocurrency through Tether and potential benefits from a Trump administration. Some traders are eyeing a potential short squeeze given the high short interest.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending amid excitement over the company's shift to quantum computing for cryptocurrency applications, particularly its partnership related to LightSolver's laser-based processing units. The community is actively discussing the potential for energy savings and comparing it to other trending quantum stocks. Some traders are closely watching its threshold list status and awaiting news of potential contracts.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members highlight its potential as a culture coin and a symbol of freedom within the digital currency space. The project is drawing attention for its association with the cannabis culture and its aim to provide a decentralized financial tool. Community is also celebrating the 420k BURN event with a livestream, calling it a significant step for the project.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is trending due to Citron Research's positive outlook, sparking significant trading volume and community discussion about a potential short squeeze. Community members are debating the company's long-term prospects, comparing it to other telehealth plays, and speculating on factors such as potential acquisitions and partnerships. Overall, the conversation centers on whether Teladoc is undervalued and poised for a breakout.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Alto Neuroscience Inc.

Alto Neuroscience is trending as traders discuss its potential for a squeeze, with some anticipating a rise to $10 or even $20. This speculation follows news of FDA Fast Track designation for ALTO-101 and investors are actively monitoring chat rooms, hoping for a breakout. The community also discusses the company's financials, pipeline and potential readouts.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is trending due to discussions surrounding potential White House talks and government funding related to rare earth minerals. Community members are speculating on a potential deal with the Trump administration to boost domestic supply and reduce reliance on China. Some traders are noting the stock's breakout, short interest, and sector momentum, while others remain skeptical.

Astrotech Corp. engages in the mass spectrometry company that launches, manages and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. Its business units include 1st Detect, BreathTech, and AgLab. The company was founded in 1984 and is headquartered in Austin, TX.

Astrotech Corp

ASTC is experiencing increased volume and momentum, leading to community speculation about a potential breakout and larger move. Some traders are attributing the increased interest to the company's expansion of operations. Others suggest possible confusion with AST SpaceMobile (ASTS) as a catalyst for the current trading activity.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a recent surge in quantum computing stocks, fueled by a $5.7 million sale of two quantum computers. Community discussions revolve around the stock's high valuation and potential for a short squeeze, with bullish investors targeting higher prices while bears anticipate a significant correction. The broader context involves the rapidly growing quantum computing sector and its speculative nature.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending as investors discuss its potential role in solving AI's energy consumption challenges, with some viewing it as a more energy-efficient alternative to classical computers. The community is actively debating the company's valuation and long-term prospects in the burgeoning quantum computing sector, especially when compared to its peers. Positive analyst coverage and potential big tech partnerships are also fueling the bullish sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Ceribell Inc. soared over 34% on Friday to mark their best session ever after the commercial-stage medical technology company said it would not be&nbsp;impacted by President Donald Trump's tariffs until the end of the year.CeriBell said in an 8-K filing that it expects no material financial impact from new U.S. tariffs until at least the fourth quarter of 2025.&nbsp;The company said it sources its headband products from two contract manufacturers in China, with final inspection and packaging done in California.&nbsp;According to Ceribell, its current U.S. inventory is expected to cover demand through the third quarter of 2025.CeriBell said it uses a first-in, first-out accounting method, which delays the tariff impact on the cost of goods sold.&nbsp;After existing inventory runs out, the company expects gross margins to drop by 8–10 percentage points, down from 87% in 2024, based on a 145% tariff rate on Chinese goods.The company added that the new tariffs would not affect subscription product revenue.CeriBell's statement&nbsp;led to a surge in the stock price and a 40.5% weekly jump in&nbsp;the stock’s follower count&nbsp;on Stocktwits — the highest among healthcare stocks.<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/CBLL_sentiment_and_message_volume_meter_as_of_April_13_png_f8d4fd0023.webp" alt="CBLL sentiment and message volume meter as of April 13.png" width="1318" height="316"><figcaption>CBLL sentiment and message volume meter as of April 13. | source: Stocktwits</figcaption></figure>Sentiment turned 'extremely bullish' from 'extremely bearish' a week ago, with one retail watcher noting that the stock was "showing high relative strength."<stembedurl>https://stocktwits.com/topstockalerts/message/611413731</stembedurl>Earlier this month, Ladenburg reportedly initiated coverage of Ceribell with a 'Buy' rating and $32 price target, which implies an over 100% upside from the last close.According to The Fly, the research firm told clients that the company has a first-mover advantage in scaling rapid electroencephalography technology for acute neurological care.CeriBell's stock has lost more than 45% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4

According to the company, its current U.S. inventory is expected to cover demand through the third quarter of 2025.

Equity

New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG

New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG New Clinical Evidence Links Ceribell Point-of-Care EEG to...

CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares CeriBell, Inc. Announces Closing of Upsized Initial...

CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering

CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering PR Newswire SUNNYVALE, Calif., Oct. 10, 2024 SUNNYVALE, Calif...

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Ceribell Inc.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$12.35
Prev Close	$11.81
Open	$11.90
Dividend Yield	0.00%
50-Day Moving Average	$12.42
Beta	1.81
Avg. Volume	261,121.71
PE Ratio	-8.60

52-Week High	$32.75
52-Week Low	$10.01
Market Capitalization	$433M
EPS (Annual)	-$1.13
Price to Book	2.51
Revenue Per Employee	$232,896.80
Enterprise Value/EBITDA	N/A

CBLL
Ceribell Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CBLL News

CBLL Ceribell Inc.